APA

Dummer R., Guminksi A., Gutzmer R., Lear J. T., Lewis K. D., Chang A. L. S., Combemale P., Dirix L., Kaatz M., Kudchadkar R., Loquai C., Plummer R., Schulze H., Stratigos A. J., Trefzer U., Squittieri N. & Migden M. R. (20210514). Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. : The British journal of dermatology.

Chicago

Dummer R, Guminksi A, Gutzmer R, Lear J T, Lewis K D, Chang A L S, Combemale P, Dirix L, Kaatz M, Kudchadkar R, Loquai C, Plummer R, Schulze H-J, Stratigos A J, Trefzer U, Squittieri N and Migden M R. 20210514. Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. : The British journal of dermatology.

Harvard

Dummer R., Guminksi A., Gutzmer R., Lear J. T., Lewis K. D., Chang A. L. S., Combemale P., Dirix L., Kaatz M., Kudchadkar R., Loquai C., Plummer R., Schulze H., Stratigos A. J., Trefzer U., Squittieri N. and Migden M. R. (20210514). Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. : The British journal of dermatology.

MLA

Dummer R, Guminksi A, Gutzmer R, Lear J T, Lewis K D, Chang A L S, Combemale P, Dirix L, Kaatz M, Kudchadkar R, Loquai C, Plummer R, Schulze H-J, Stratigos A J, Trefzer U, Squittieri N and Migden M R. Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. : The British journal of dermatology. 20210514.